Pharmaceutical Giant

Dr. Kevin Williams Issues Caution to African Americans About Rare Heart Disease

Stacy M. Brown NNPA Newswire Senior National CorrespondentMay 27, 2021

With the most recent collaboration between Pfizer Rare Disease and the Black Press, the organizations embarked on a mission to educate and raise awareness to transthyretin amyloid cardiomyopathy – or ATTR-CM. “ATTR-CM is a rare, life-threatening, underrecognized, and underdiagnosed type of amyloidosis that affects the heart and it is associated with heart failure,” Dr. Kevin Williams, Pfizer’s chief medical officer, told the NNPA in a live interview.

Pharmaceutical Giant Eli Lilly Meets with Multicultural Groups

NNPA NewswireNovember 15, 2017

Nineteen leaders of select, national multicultural organizations visited the headquarters of Eli Lilly and Company, the global pharmaceutical maker, for an all-day “learning lab” about the pharmaceutical industry’s role in the healthcare system. Attendees heard from Lilly’s senior leadership team, as well as, individuals working in clinical trials, research, manufacturing and medicine. Attendees also toured a drug development lab, participated in informational sessions on healthcare topics, and learned about the variety of diversity and inclusion initiatives underway at Lilly.